Ethanol Extract of Gentiana straminea Maxim Displays Anti-Hypoxia Effects by Regulating Antioxidant Enzymes and Energy Metabolism

Dan Song1,2, Ming-Juan Ge3, Jie Li1,2, Yi Jiang1, Xiu-Mei Kong1, Jiao-Jiao Xu1, Xu Ji1,2, Rui-Xin Shi1 and Qin Zhao1,2*

1Joint Laboratory for Research on Active Components and Pharmacological Mechanism of Tibetan Materia Medica of Tibetan Medical Research Center of Tibet, School of Medicine, Xizang Minzu University, Xianyang 712082, Shaanxi, China

2Engineering Research Center of Tibetan Medicine Detection Technology, Ministry of Education, School of Medicine, Xizang Minzu University, Xianyang 712082, Shaanxi, China

3Xianyang Hospital of Yan’an University, Xianyang 712000, Shaanxi, China

ABSTRACT

Oxygen is an essential regulator for normal aerobic metabolism in humans and animals, oxidative stress and energy metabolism during hypoxia may be related to hypoxia-related diseases. Gentiana straminea Maxim (G. straminea), a natural Tibetan herb with exerts several biological effects, was used to study the anti-hypoxia effects of its ethanol extract. Three extract methods were employed to evaluate the best extraction methods. Male Kunming specific pathogen-free (SPF) mice were randomly divided into blank control, model (hypoxia), positive (propranolol 30 mg/kg + hypoxia), and three G. straminea ethanol extracts dose groups (10, 5 and 2.5 g/kg respectively + hypoxia), administered intragastrically once a day for 14 consecutive days. After that, multiple hypoxia experiments were conducted including soda lime normobaric hypoxia test, sodium nitrite poisoning test, isoproterenol poisoning test, and acute cerebral ischemic hypoxia test. Subsequently, the content of superoxide dismutase (SOD), malondialdehyde (MDA), and activity of total antioxidant capacity (T-AOC), catalase (CAT) in mice liver were measured; while SOD and MDA contents and activity of T-AOC, CAT, Na+-K+-ATPase, Ca2+-Mg2+-ATPase, pyruvate kinase (PK) and phosphofructokinase (PFK) in mice brain were evaluated. In the results, G. straminea ethanol extract markedly enhanced hypoxia tolerance in mice. It attenuated hypoxia-induced oxidative stress by reducing MDA levels (in liver and brain), and elevating SOD (in liver and brain), T-AOC and CAT (in liver). Furthermore, pre-treatment with G. straminea ethanol extracts significantly increased ATP content, up-regulated the activity of Na+-K+-ATPase, Ca2+-Mg2+-ATPase, PK, and PFK in hypoxia mice brain. In conclusion, this research demonstrated the anti-hypoxia activity of ethanol extract of G. straminea, which may be related to increased energy metabolism. Our findings provide a basis for investigating hypoxia-related diseases and drug development.

Article Information

Received 14 July 2022

Revised 20 April 2023

Accepted 24 May 2023

Available online 20 June 2023

(early access)

Published 16 December 2023

Authors’ Contribution

Conceptualization and methodology: DS, M-JG and QZ. Investigation: DS, M-JG and JL. Validation: YJ, X-MK, J-JX and R-XS. Software: DS and JL. Visualization: XJ. Writing original draft preparation: DS. Funding acquisition, writing review and editing: DS and QZ. Project administration: QZ. All authors have read and agreed to the published version of the manuscript.

Key words

Gentiana straminea Maxim, Ethanol extract, Anti-hypoxia, Antioxidant, Energy metabolism

DOI: https://dx.doi.org/10.17582/journal.pjz/20220714100706

* Corresponding author: [email protected]

0030-9923/2024/0001-0237 $ 9.00/0

Copyright 2024 by the authors. Licensee Zoological Society of Pakistan.

This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).

INTRODUCTION

Oxygen plays a vital role in regulating aerobic metabolism by serving as a key regulator of cell energy production and enzyme activation (Lu et al., 2020). Hypoxia refers to abnormal changes in the morphology, metabolism, and function of tissues and organs caused by insufficient oxygen supply or oxygen dysfunction (Murray et al., 2018). Hypoxia is a central factor in acute and chronic altitude sickness (Avellanas, 2018), and can be caused by factors such as low oxygen content and pressure, impaired oxygen transport, and impaired cellular oxygen uptake or utilization (MacIntyre, 2014). Hypoxia is involved in the development of hypertension, cardiovascular and metabolic disorders, and respiratory diseases. The oxidative stress during hypoxia may be causally related to these diseases (McGarry et al., 2018).

Mitochondria produce energy by using a variety of energy sources. Energy is transferred between cells in the form of adenosine triphosphate (ATP) to support cell activity. Mitochondrial energy metabolism is highly regulated to continuously meet the energy demands of cells (Benard et al., 2010). Mitochondria are significant targets of hypoxic injury, which involves the production of reactive oxygen species (ROS) (Ham and Raju, 2017). ROS includes hydrogen peroxide, hydroxyl radicals, and superoxide anions essential for normal cell function (Finkel and Holbrook, 2000). The cellular antioxidant system typically removes ROS; however, ROS production overwhelms antioxidant capacity in hypoxic injury, leading to DNA damage, lipid peroxidation, and mitochondrial membrane depolarization (Bhat et al., 2015). These mechanisms lead to the release of cytochrome C and apoptosis (Lemasters et al., 2009; Murphy and Steenbergen, 2008; Wu and Bratton, 2013). Hypoxia causes insufficient oxygen supply to various organs, inhibits oxidation, promotes glycolysis, and leads to insufficient ATP production (Liu et al., 2020). As a result, tissues and organs undergo apoptosis due to a lack of ATP and energy with subsequent tissue damage (Bickler et al., 2017). Hypoxic damage can be substantially reduced if a cell’s anti-hypoxia ability is enhanced, and energy metabolism can improve (Ferraresi et al., 2015). Inadequate oxygen supply reduces intracellular oxygen partial pressure, leading to mitochondrial dysfunction and affecting energy metabolism (Li et al., 2021).

Anoxia occurs at high altitude such as the Tibet Plateau where the acute altitude response has become a serious problem. In addition, physiological conditions such as ischemia, stroke, neurodegenerative disease, cardiovascular injury and other pathological conditions can also lead to hypoxia (Heinicke et al., 2003; Katayama et al., 2004; Savourey et al., 1996). In high altitude hypoxia environment, a series of stress reactions will occur in the body, resulting in organ hypoxia damage. Among them, oxidative stress damage, immune system damage and disturbance of cellular energy metabolism are the main mechanisms.

Under hypoxic environment, the antioxidant capacity of the body is disordered, and the brain and other organs may die due to insufficient energy supply (Jiao et al., 2019). Although drugs such as dexamethasone, acetazolamide, propranolol, and carbamazepine are used to treat hypoxic diseases, some of these have slow curative effects and are burdened by side effects. They are not suitable for long-term use (Khambatta et al., 1987; Reddy et al., 2013; Shimoda et al., 2021). Therefore, identifying natural, nontoxic and effective anti-hypoxia bioactive substances is vital and urgent.

Tibet’s special climate and geographical environment have formed rich medicinal plants and mineral resources with unique curative effects. Using Tibet’s unique plateau plant resources, developing high-quality and efficient anti-hypoxia drugs has become possible. Gentiana straminea Maxim (G. straminea), also called as “Jiejigabao” in Tibetan, is an important Tibetan medicine (Zhou et al., 2021). The chemical constituents of G. straminea are complex and diverse, including iridoids, triterpenes, flavonoids, alkaloids, steroids, and carbohydrates (Kakuda et al., 2001; Pan et al., 2016; Yang et al., 2014). G. straminea is mainly used for the treatment of rheumarthritis, icterepatitis, constipation, pain and hypertension (Tan et al., 1996; Yu et al., 2004). Pharmacological studies reported that G. straminea exhibits several pharmacological properties, including analgesic, anti-hypoxia, anti-inflammatory, anti-bacterial, antihypertensive, hepatoprotective, diuretic, antipyretic, immune regulation, and free radical scavenging properties (Song et al., 2022). However, few studies have reported the effect of G. straminea on energy metabolism.

This research demonstrated the effects of G. straminea on normobaric hypoxia using animal models, and provided an experimental basis for studying hypoxic diseases and novel drug development.

MATERIALS AND METHODS

Materials, main reagents and animals

Gentiana straminea Maxim (G. straminea) was purchased from Tibetan Medicine Co., Ltd. (Lhasa, China). Soda lime was procured from Beijing Deerli Soda Lime Factory (Beijing, China). Propranolol was obtained from Shanxi Linfen Jianmin Pharmaceutical Factory Co., Ltd. (Shanxi, China).

The superoxide dismutase (SOD) kit, malondialdehyde (MDA) kit, ATP kit, ATPase kit, pyruvate kinase (PK) kit, phosphofructokinase (PFK) kit, total antioxidant capacity (T-AOC) kit, and catalase (CAT) kit were procured from Nanjing Jiancheng Bioengineering Institute (Nanjing, China). The cell counting kit-8 (CCK-8) was purchased from Sangon Biotech (Shanghai, China).

Specific pathogen-free male Kunming mice were obtained from Chengdu Dossy Experimental Animals Co., Ltd. (Chengdu, China). They were housed in a standard laboratory environment with a 12 h light-dark cycle, regular chow, and ad libitum water.

Preparation of G. straminea extracts

To evaluate the effect of different extraction methods on the anti-hypoxia properties, three extraction methods were used to prepare G. straminea extracts as described by Song et al. (2022), including water extraction, water extraction and alcohol precipitation, as well as ethanol extraction (Table I).

 

Table I. Preparation of three different extracts from G. straminea.

Extract method	Operation steps
Water extraction	100 g G. straminea were added to 500 mL ddH2O at 100°C for 1 h twice, then filtered to obtain water extract. The filtrate was stored at 4°C for further use.
Water extraction and alcohol precipitation	100 g G. straminea were added to 1000 mL ddH2O for 24 h, then boiled for 3 times, 0.5 h each time, and added 1000 mL ddH2O each time. Water extraction were collected, and centrifuged at 2500 rpm for 0.5 h, take the supernatant and concentrated to 100 mL. To get the water extraction and alcohol precipitation, 95% ethanol were added to the concentrated, followed by vacuum rotary evaporation to evaporate the ethanol to reach a final volume of 100 mL.
Ethanol extraction	100 g G. straminea were added to 500 mL 95% ethanol for 24 h, then heated to reflux for 1.5 h, followed by vacuum rotary evaporation to evaporate the ethanol. Finally, to obtain the ethanol extract, ddH2O was added to reach a final volume of 100 mL

 

Five groups were set up (n= 6 per group): model group (phosphate-buffered saline, PBS), propranolol group (30 mg/kg), and three G. straminea extract groups (10 g/kg water extraction, 10 g/kg water extraction and alcohol precipitation, 10 g/kg ethanol extraction. The mice were intragastrically administered their respective treatments doses once a day for 14 consecutive days. After 30 min of the last administration, all the mice were challenged with soda lime, and their survival time in each group was recorded.

Animal treatments

To further assess the anti-hypoxia effects of different concentrations of ethanol extract of G. straminea, thirty-six mice were randomly divided into 6 groups (n= 6 per group): blank control; model (hypoxia treatment only); positive groups (30 mg/kg propranolol for hypoxia treatment); and three G. straminea ethanol extract dose groups (10, 5, and 2.5 g/kg respectively for hypoxia treatment). Mice in control and model groups received PBS administration, while mice in positive group and G. straminea dose groups were administered intragastrically once a day for 14 consecutive days. After 30 min of the last administration, all mice in each group except the control were challenged with subsequently treatments.

Soda lime normobaric hypoxia test

Each mouse in model, positive and three G. straminea ethanol extract dose groups was placed in a 250-mL tank (1 mouse in each tank) containing 15 g of soda lime and tightly covered with vaseline around the neck. The survival time was recorded (Li et al., 2021; Yang et al., 2019).

Sodium nitrite (NaNO2) poisoning test

Mice were intraperitoneally injected with 240 mg/kg NaNO2, and their survival time was recorded accordingly (Li et al., 2021; Yang et al., 2019).

Isoproterenol poisoning test

Mice were intraperitoneally injected with 15 mg/kg isoproterenol. After 15 min, the mice were placed in a 250-mL tank (1 mouse in each tank) containing 15 g of soda lime, and the neck was tightly covered with petroleum jelly. The time of death was then recorded (Cai et al., 2011).

Acute cerebral ischemic hypoxia test

Mice were decapitated. The time from decapitation to cessation of wheezing were recorded (Li et al., 2021).

Tissues collection and indicators determination

At the end of the above soda lime normobaric hypoxia test, all the mice including control group were sacrificed. Their liver and brain tissues were washed twice with precooled PBS, dried and weighed for tissue homogenate. Using the ratio of tissue weight (g) to PBS (mL) of 1:9, liver and brain tissues were homogenized in an ice bath and centrifuged at 4°C, 3000 rpm for 10 min to separate the supernatants. The concentrations of SOD, MDA, T-AOC and CAT in the liver, and the SOD, MDA, ATP, Na+-K+-ATPase, Ca2+-Mg2+-ATPase, PK and PFK content in the brain were determined using the commercial kits.

Statistical analysis

The experiments were expressed as the mean ± standard deviation (SD). One-way analysis of variance (ANOVA) was used for multiple comparisons, and differences with P <0.05 were considered statistically significant.

RESULTS

Anti-hypoxia effects of three different extraction methods of G. straminea in mice

The anti-hypoxia effects of three different extraction methods of G. straminea on mice were compared by measuring the survival time. As shown in Figure 1, no significant difference in the survival time of mice among the water extraction group, water extraction and alcohol precipitation group, and model group under normobaric hypoxia tests. However, compared with model group, the survival time of mice in G. straminea ethanol extract group was significantly extended, indicating that ethanol extraction method was effective, and therefore had a significant anti-hypoxia effect on mice compared to other two methods.

 

Anti-hypoxia effect of different concentrations of G. straminea ethanol extract

To investigate the anti-hypoxia activity of G. straminea ethanol extract, we conducted various hypoxia experiments, including soda lime normobaric hypoxia test, NaNO2 poisoning, isoproterenol hypoxia, and an acute cerebral ischemic hypoxia test. Compared with the hypoxia-only group, the ethanol extract prolonged the survival time of mice under various hypoxia experiments, confirming its anti-hypoxia effect (Fig. 2). These results indicated that G. straminea ethanol extract increased hypoxia tolerance.

Ethanol extraction of G. straminea alleviates liver oxidative stress

To determine the antioxidant activity of the ethanol extract of G. straminea, mice were intragastrically administered with PBS, propranolol and various doses of ethanol extract (10, 5, 2.5 g/kg) for 14 days, respectively. Subsequently, the mice were challenged with soda lime normobaric hypoxia, whereas the blank control group gavaged with PBS only. Hepatic SOD activity was markedly lower in the normobaric hypoxia model group compared with the control group. However, pre-treatment with the ethanol extract of G. straminea (5 and 10 g/kg) significantly improved SOD activity in hypoxia mice (Fig. 3A). MDA content obviously increased in the normobaric hypoxia model group compare to the control group; ethanol extract of G. straminea administration decreased hepatic MDA content compared to the model group, although the difference was not statistically significant (Fig. 3B).

 

The influence of ethanol extract of G. straminea on hepatic T-AOC and CAT in hypoxic mice was further explored. Normobaric hypoxia attenuated T-AOC and CAT activity, while pre-treatment with ethanol extract of G. straminea increased enzymatic activity in hypoxia mice groups (Fig. 3C, D). Thus, these results suggest that the anti-hypoxic effect of G. straminea ethanol extract was associated with its antioxidant and oxidase-regulating activities.

 

Effect of G. straminea ethanol extract on lipid peroxidation and energy metabolism in hypoxia model mice brain

The SOD and MDA levels in brain tissues were measured to determine the degree of lipid peroxidation in mice brain. Compared with the control group, the content of SOD in rice brain was obviously lower, while MDA level was significantly higher in normobaric hypoxia model mice. Pre-treatment with G. straminea ethanol extract for 14 days significantly increased SOD level and slightly decreased MDA content compared to the model group (Fig. 4A, B).

ATP plays a critical role in cellular metabolism by storing and transferring chemical energy, serving as the primary energy source for living organisms. Compared with model mice under normobaric hypoxia, after 14 days of G. straminea ethanol extract administration, ATP content, and activities of Na+-K+-ATPase and Ca+-Mg+-ATPase in mice brain were restored (Fig. 4C, E). PK and PFK are essential enzymes involved in energy metabolism via glycolysis. Under normal circumstances, PK and PFK exhibit lower activity levels. However, PK and PFK were induced by hypoxia due to the consumption of ATP (Fig. 4F, G). PK and PFK activities were enhanced by G. straminea ethanol extract pre-treatment. The results showed that when the mice were in a hypoxic state, the hypoxic environment activated PF and PFK. Anaerobic glycolysis provides essential energy sources, thereby improves the ability to resist hypoxia, and prolongs survival. These findings suggest that the anti-hypoxia activity of G. straminea ethanol extract might be based on its regulation of ATP and energy metabolism.

 

DISCUSSION

The brain consumes one quarter of the body’s oxygen, and insufficient oxygen supply can lead to brain damage or even brain death (Ferrer, 1973; Lenart, 2017). To investigate the potential protective effects of G. straminea extract, both liver and brain tissues were collected for the present study. Our results demonstrated that ethanol extract of G. straminea markedly enhanced mice’s anti-hypoxia capability through ameliorating their anti-oxidative ability and energy metabolism. Breathing time can be used as an important indicator to evaluate the effect of hypoxia protection. In this work, the ethanol extract of G. straminea intervention significantly prolonged the respite time of hypoxic mice, indicating its potential anti-hypoxia effects. During hypoxia, the body undergoes anaerobic respiration, resulting in the accumulation of incomplete oxidation products, consequently leading to increased oxidative damage in mice tissues. Generally, the contents of SOD and MDA are essential indicator for lipid peroxidation. The results showed ethanol extract of G. straminea significantly induced SOD content and reduced MDA content in liver and brain. Furthermore, it significantly improved hepatic T-AOC and CAT activities, decreased free radical accumulation and accelerated lipid peroxides elimination.

Hypoxia disrupts normal oxidative decomposition function, and glycolysis is the primary short-term energy source (Fernie et al., 2004). ATP molecules serve as the direct substrate for energy, providing energy for cellular metabolism, and responsible for the storage and transmission of chemical energy (Miao et al., 2014). Our findings suggested that G. straminea ethanol extract pre-treatment significantly increased ATP content, Na+-K+-ATPase and Ca+-Mg+-ATPase activities, and enhanced PK and PFK activity, indicating that the mechanism of G. straminea ethanol extract may be related to increased energy metabolism. This study implies that the anti-hypoxia activity of G. straminea depends on its regulation of energy metabolism. Further research is needed to explore its in-depth mechanisms of the anti-hypoxic effect and its potential as a therapeutic agent.

CONCLUSION

In this study, we demonstrated the anti-hypoxia effects of G. straminea ethanol extract in vivo on mice under various hypoxia conditions. Our results showed that the ethanol extract of G. straminea significantly improved the survival time and increased their tolerance to hypoxia. Moreover, the anti-hypoxic effect is associated with the regulation of antioxidant enzyme activities and energy metabolism. These findings provide evidence and a molecular insight that G. straminea can serve as a potential natural anti-hypoxia agent and be used for prevention and treatment of hypoxic diseases, as well as in the design of anti-hypoxia drugs.

Funding

This work was supported by National Natural Science Foundation of China (Grant No. 81660722, 32160165), Natural Science Foundation of Tibet Autonomous Region (Grant No. XZ202101ZD0016G, XZ202101ZR0076G, XZ202201ZR0065G), COVID-19 Emergency Response Program of Xizang Minzu University (Grant No. XZMDYJ02), and the Cultivation Project of National Natural Science Foundation of Xizang Minzu University (Grant No. XZMU-M2022N01).

IRB approval

This study did not involve humans; therefore, no IRB approval is needed.

Ethical statement

Research experiments conducted in this article with animals were approved by the Laboratory Animal Ethics Committee of Xizang Minzu University (Certify No.: 20200-7) following all guidelines, regulations, legal, and ethical standards as required for animals.

Statement of conflict of interest

The authors have declared no conflict of interest.

References

Avellanas, C.M.L., 2018. A journey between high altitude hypoxia and critical patient hypoxia: What can it teach us about compression and the management of critical disease? Med. Intensiva. (Engl. Ed.), 42: 380-390. https://doi.org/10.1016/j.medine.2018.05.013

Benard, G., Bellance, N., Jose, C., Melser, S., Nouette-Gaulain, K. and Rossignol, R., 2010. Multi-site control and regulation of mitochondrial energy production. Biochim. biophys. Acta, 1797: 698-709. https://doi.org/10.1016/j.bbabio.2010.02.030

Bhat, A.H., Dar, K.B., Anees, S., Zargar, M.A., Masood, A., Sofi, M.A. and Ganie, S.A., 2015. Oxidative stress, mitochondrial dysfunction and neurodegenerative diseases; a mechanistic insight. Biomed. Pharmacother., 74: 101-110. https://doi.org/10.1016/j.biopha.2015.07.025

Bickler, P.E., Feiner, J.R., Lipnick, M.S., Batchelder, P., MacLeod, D.B. and Severinghaus, J.W., 2017. Effects of acute, profound hypoxia on healthy humans: implications for safety of tests evaluating pulse oximetry or tissue oximetry performance. Anesth. Analg., 124: 146-153. https://doi.org/10.1213/ANE.0000000000001421

Cai, Y., Lu, Y., Chen, R., Wei, Q. and Lu, X., 2011. Anti-hypoxia activity and related components of Rhodobryum giganteum par. Phytomedicine, 18: 224-229. https://doi.org/10.1016/j.phymed.2010.06.015

Fernie, A.R., Carrari, F. and Sweetlove, L.J., 2004. Respiratory metabolism: glycolysis, the TCA cycle and mitochondrial electron transport. Curr. Opin. Pl. Biol., 7: 254-261. https://doi.org/10.1016/j.pbi.2004.03.007

Ferraresi, C., de Sousa, M.V., Huang, Y.Y., Bagnato, V.S., Parizotto, N.A. and Hamblin, M.R., 2015. Time response of increases in ATP and muscle resistance to fatigue after low-level laser (light) therapy (LLLT) in mice. Lasers med. Sci., 30: 1259-1267. https://doi.org/10.1007/s10103-015-1723-8

Ferrer, S., 1973. Hipoxia cerebral [Cerebral hypoxia]. Rev. Med. Chil., 101: 393-402.

Finkel, T. and Holbrook, N.J., 2000. Oxidants, oxidative stress and the biology of ageing. Nature, 408: 239-247. https://doi.org/10.1038/35041687

Ham, P.B., and Raju, R., 2017. Mitochondrial function in hypoxic ischemic injury and influence of aging. Prog. Neurobiol., 157: 92-116. https://doi.org/10.1016/j.pneurobio.2016.06.006

Heinicke, K., Prommer, N., Cajigal, J., Viola, T., Behn, C. and Schmidt, W., 2003. Long-term exposure to intermittent hypoxia results in increased hemoglobin mass, reduced plasma volume, and elevated erythropoietin plasma levels in man. Eur. J. appl. Physiol., 88: 535-543. https://doi.org/10.1007/s00421-002-0732-z

Jiao, Y., Kuang, H., Wu, J. and Chen, Q., 2019. Polysaccharides from the edible mushroom Agaricus bitorquis (Quel.) Sacc. Chaidam show anti-hypoxia activities in pulmonary artery smooth muscle cells. Int. J. mol. Sci., 20: 637. https://doi.org/10.3390/ijms20030637

Kakuda, R., Iijima, T., Yaoita, Y., Machida, K. and Kikuchi, M., 2001. Secoiridoid glycosides from Gentiana scabra. J. nat. Prod., 64: 1574-1575. https://doi.org/10.1021/np010358o

Katayama, K., Sato, K., Matsuo, H., Ishida, K., Iwasaki, K. and Miyamura, M., 2004. Effect of intermittent hypoxia on oxygen uptake during submaximal exercise in endurance athletes. Eur. J. appl. Physiol., 92: 75-83. https://doi.org/10.1007/s00421-004-1054-0

Khambatta, H.J., Stone, J.G., Askanazi, J. and Khan, E., 1987. Propranolol increases oxygen utilization during hypoxia. Br. J. Anaesth., 59: 1171-1176. https://doi.org/10.1093/bja/59.9.1171

Lemasters, J.J., Theruvath, T.P., Zhong, Z. and Nieminen, A.L., 2009. Mitochondrial calcium and the permeability transition in cell death. Biochim. biophys. Acta, 1787: 1395-1401. https://doi.org/10.1016/j.bbabio.2009.06.009

Lenart, J., 2017. Mitochondria in brain hypoxia. Postepy Hig. Med. Dosw. (Online), 71: 118-128. https://doi.org/10.5604/01.3001.0010.3796

Li, D., Ren, J., Wang, T., Wu, L., Liu, P. and Li, Y., 2021. Anti-hypoxia effects of walnut oligopeptides (Juglans regia L.) in mice. Am. J. Transl. Res., 13: 4581-4590.

Liu, C., Shao, C., Du, Q., He, C., Sun, X., Lou, A., Ma, Z. and Yu, J., 2020. Mechanism and effects of fructose diphosphate on anti-hypoxia fatigue and learning memory ability. Can. J. Physiol. Pharmacol., 98: 733-740. https://doi.org/10.1139/cjpp-2019-0690

Lu, H., Jiao, Z., Jiao, Y., Wang, W. and Chen, Q., 2020. Phenolic acids-rich fractions from Agaricus bitorguis (Quel.) Sacc. Chaidam ZJU-CDMA-12 mycelia modulate hypoxic stress on hypoxia-damaged PC12 cells. Molecules, 25: 4845. https://doi.org/10.3390/molecules25204845

MacIntyre, N.R., 2014. Tissue hypoxia: Implications for the respiratory clinician. Respir. Care, 59: 1590-1596. https://doi.org/10.4187/respcare.03357

McGarry, T., Biniecka, M., Veale, D.J. and Fearon, U., 2018. Hypoxia, oxidative stress and inflammation. Free Radic. Biol. Med., 125: 15-24. https://doi.org/10.1016/j.freeradbiomed.2018.03.042

Miao, M.S., Jiang, M.Q. and Zhang, X. Y., 2014. Study of Shenqi Huafen Pian on exercise-induced fatigue in rats. Chin. J. exp. Tradit. Med. Formulae, 20: 177-179.

Murphy, E. and Steenbergen, C., 2008. Mechanisms underlying acute protection from cardiac ischemia-reperfusion injury. Physiol. Rev., 88: 581-609. https://doi.org/10.1152/physrev.00024.2007

Murray, A.J., Montgomery, H.E., Feelisch, M., Grocott, M.P.W. and Martin, D.S., 2018. Metabolic adjustment to high-altitude hypoxia from genetic signals to physiological implications. Biochem. Soc. Trans., 46: 599-607. https://doi.org/10.1042/BST20170502

Pan, Y., Zhao, Y.L., Zhang, J., Li, W.Y. and Wang, Y.Z., 2016. Phytochemistry and pharmacological activities of the genus Gentiana (Gentianaceae). Chem. Biodivers., 13: 107-150. https://doi.org/10.1002/cbdv.201500333

Reddy, A.K., Sriganesh, K. and Rao, G.S., 2013. Hypoxia and chest radiography changes after low-dose, short-duration carbamazepine therapy. J. Neurosurg. Anesthesiol., 25: 210-212. https://doi.org/10.1097/ANA.0b013e318285bbd9

Savourey, G., Garcia, N., Besnard, Y., Guinet, A., Hanniquet, A.M. and Bittel, J., 1996. Pre-adaptation, adaptation and de-adaptation to high altitude in humans: Cardio-ventilatory and haematological changes. Eur. J. appl. Physiol. Occup. Physiol., 73: 529-535. https://doi.org/10.1007/BF00357675

Shimoda, L.A., Suresh, K., Undem, C., Jiang, H., Yun, X., Sylvester, J.T. and Swenson, E.R., 2021. Acetazolamide prevents hypoxia-induced reactive oxygen species generation and calcium release in pulmonary arterial smooth muscle. Pulm. Circ., 11: 20458940211049948. https://doi.org/10.1177/20458940211049948

Song, D., Zhang, J., Li, J., Kong, X., Jiang, Y., Xu, J., Zhang, X. and Zhao, Q., 2022. Effective parts of Gentiana straminea Maxim attenuates hypoxia-induced oxidative stress and apoptosis. Dose Response, 20: 15593258221100986. https://doi.org/10.1177/15593258221100986

Tan, R.X., Wolfender, J.L., Zhang, L.X., Ma, W.G., Fuzzati, N., Marston, A. and Hostettmann, K., 1996. Acyl secoiridoids and antifungal constituents from Gentiana macrophylla. Phytochemistry, 42: 1305-1313. https://doi.org/10.1016/0031-9422(96)00149-5

Wu, C.C. and Bratton, S.B., 2013. Regulation of the intrinsic apoptosis pathway by reactive oxygen species. Antioxid. Redox Signal., 19: 546-558. https://doi.org/10.1089/ars.2012.4905

Yang, D., Lian, J., Wang, L., Liu, X., Wang, Y., Zhao, X., Zhang, X. and Hu, W., 2019. The anti-fatigue and anti-anoxia effects of Tremella extract. Saudi J. biol. Sci., 26: 2052-2056. https://doi.org/10.1016/j.sjbs.2019.08.014

Yang, H., Liu, J., Chen, S., Hu, F. and Zhou, D., 2014. Spatial variation profiling of four phytochemical constituents in Gentiana straminea (Gentianaceae). J. nat. Med., 68: 38-45. https://doi.org/10.1007/s11418-013-0763-2

Yu, F., Yu, F., Li, R. and Wang, R., 2004. Inhibitory effects of the Gentiana macrophylla (Gentianaceae) extract on rheumatoid arthritis of rats. J. Ethnopharmacol., 95: 77-81. https://doi.org/10.1016/j.jep.2004.06.025

Zhou, D., Lv, D., Zhang, H., Cheng, T., Wang, H., Lin, P., Shi, S., Chen, S. and Shen, J., 2021. Quantitative analysis of the profiles of twelve major compounds in Gentiana straminea Maxim. roots by LC-MS/MS in an extensive germplasm survey in the Qinghai-Tibetan plateau. J. Ethnopharmacol., 280: 114068. https://doi.org/10.1016/j.jep.2021.114068